Average Insider

Where insiders trade, we follow

$ROIV
Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne, myasthenia gravis, warm autoimmune hemolytic anemia, thyroid eye diseases, sarcoidosis, and staph aureus bacteremia. The company was founded in 2014 and is based in London, the United Kingdom.
Healthcare
Sector
Biotechnology
Industry
Matthew Gline
CEO
908
Employees
$38.73
Current Price
$19.67B
Market Cap
52W Low$19.96
Current$38.7383.3% above low, 16.7% below high
52W High$42.50

Insider Activity Statistics

Aggregated buying and selling activity by time period
PeriodTypeInsidersTransactionsValueSharesBuy/Sell Ratio
1 weekBuys00--All Sells
Sells321$160,610,214.034,145,286
2 weeksBuys00--All Sells
Sells527$180,700,560.294,633,229
1 monthBuys00--All Sells
Sells529$195,280,560.295,033,229
2 monthsBuys00--All Sells
Sells634$210,268,088.815,450,979
3 monthsBuys00--All Sells
Sells741$218,618,863.255,681,029
See activity going back 12 months โ€” create a free account

Insider Transactions

Recent purchases and sales by company insiders
DateInsiderTypeSharesPriceValueActions
Nov 16, 2026
MANCHESTER KEITH S
Director
Sale18,927$38.99$737,963.73View Details
Nov 17, 2026
MANCHESTER KEITH S
Director
Sale75,716$38.24$2,895,379.84View Details
Nov 17, 2026
MANCHESTER KEITH S
Director
Sale525,507$38.24$20,095,387.68View Details
Nov 16, 2026
MANCHESTER KEITH S
Director
Sale550,280$39.17$21,554,467.60View Details
Nov 16, 2026
MANCHESTER KEITH S
Director
Sale131,073$38.99$5,110,536.27View Details
Nov 17, 2026
MANCHESTER KEITH S
Director
Sale798$38.24$30,515.52View Details
Nov 16, 2026
MANCHESTER KEITH S
Director
Sale79,461$39.17$3,112,487.37View Details
Nov 16, 2026
Gold Daniel Allen
Director
Sale550,280$39.17$21,554,467.60View Details
Nov 17, 2026
Gold Daniel Allen
Director
Sale525,507$38.24$20,095,387.68View Details
Nov 16, 2026
Gold Daniel Allen
Director
Sale79,461$39.17$3,112,487.37View Details
Nov 17, 2026
Gold Daniel Allen
Director
Sale75,716$38.24$2,895,379.84View Details
Nov 16, 2026
Gold Daniel Allen
Director
Sale131,073$38.99$5,110,536.27View Details
Nov 16, 2026
Gold Daniel Allen
Director
Sale18,927$38.99$737,963.73View Details
Nov 17, 2026
Gold Daniel Allen
Director
Sale798$38.24$30,515.52View Details
Nov 16, 2026
QVT Financial LP
Director by Deputization
Sale131,073$38.99$5,110,536.27View Details
Nov 17, 2026
QVT Financial LP
Director by Deputization
Sale75,716$38.24$2,895,379.84View Details
Nov 16, 2026
QVT Financial LP
Director by Deputization
Sale550,280$39.17$21,554,467.60View Details
Nov 17, 2026
QVT Financial LP
Director by Deputization
Sale798$38.24$30,515.52View Details
Nov 16, 2026
QVT Financial LP
Director by Deputization
Sale18,927$38.99$737,963.73View Details
Nov 17, 2026
QVT Financial LP
Director by Deputization
Sale525,507$38.24$20,095,387.68View Details

Upcoming Earnings

Scheduled earnings reports
No upcoming earnings scheduled

Past Earnings

Historical earnings results
Nov 9, 2026
EPS
Estimated-$0.37
Actual-$0.24
Beat
Revenue
Estimated$4.34M
Actual$35.12M
Beat
3 more earnings records available โ€” create a free account to see 12 months of history
Version: v26.11.1